Bicarbonate induces high-level resistance to the human antimicrobial peptide LL-37 in Staphylococcus aureus small colony variants by Zhang, P et al.
Bicarbonate induces high-level resistance to the human antimicrobial
peptide LL-37 in Staphylococcus aureus small colony variants
Ping Zhang1, John A. Wright2, Anna Tymon1 and Sean P. Nair1*
1Department of Microbial Diseases, UCL Eastman Dental Institute, 256 Gray’s Inn Road, London WC1X 8LD, UK; 2Immunology Catalyst,
GSK, Stevenage, Hertfordshire, UK
*Corresponding author. Tel: !44-(0)2034561118; Fax: !44-(0)2034561127; E-mail: Sean.Nair@ucl.ac.uk
Received 22 August 2017; returned 4 October 2017; revised 13 October 2017; accepted 25 October 2017
Objectives: Staphylococcus aureus small colony variants (SCVs) cause persistent infections and are resistant to
cationic antibiotics. Antimicrobial peptides (AMPs) have been suggested as promising alternatives for treating
antibiotic-resistant bacteria. We investigated the capacity of the human cationic AMP LL-37 to kill SCVs in the
presence of physiological concentrations of bicarbonate, which are reported to alter bacterial membrane perme-
ability and change resistance of bacteria to AMPs.
Methods: MBCs of LL-37 for S. aureus SCVs with mutations in different genes in the presence and absence of
bicarbonate were determined.
Results: In the absence of bicarbonate, SCVs of S. aureus strains LS-1 and 8325-4 had the same level of resistance
to LL-37 as the parental strain (8 mg/L). In the presence of bicarbonate, hemB, menD and aroD SCVs of LS-1 had
high-level resistance to LL-37 (128 mg/L) compared with the parental strain (16 mg/L). However, only the aroD
SCV of strain 8324-5 showed high-level resistance. 8325-4 harbours mutations in two genes, tcaR and rsbU, which
are involved in antimicrobial sensing and the stress response, respectively. When rsbUwas repaired in 8325-4 it dis-
played high-level resistance to LL-37 in the presence of bicarbonate. This phenotype was lost when tcaR was also
repaired, demonstrating that RsbU and TcaR are involved in LL-37 resistance in the presence of bicarbonate
Conclusions: S. aureus SCVs would be resistant to high concentrations of LL-37 in niches where there are physio-
logical concentrations of bicarbonate and therefore this AMP may not be effective in combating SCVs.
Introduction
Small colony variants (SCVs) are slow-growing subpopulations of
bacteria. Staphylococcus aureus SCVs are associated with persis-
tent and recurrent infections such as osteomyelitis, implant infec-
tions, airway infections in cystic fibrosis patients1 and patients
receiving long-term antibiotic treatment.2–4 S. aureus SCVs isolated
from patients are often found to be auxotrophic for metabolites,
such as haemin and menadione.5 These two auxotrophs arise due
to spontaneous mutations in genes encoding proteins in the haem
and menadione biosynthesis pathways, with the most commonly
studied mutations being inhemB ormenD.6 Haem and menadione
are required for the biosynthesis of some components of the elec-
tron transport chain (ETC). Therefore the ETC is interrupted in
haemin or menadione auxotrophic SCVs.7 A functional ETC gener-
ates an electrochemical gradient (DW) across the cytoplasmic
membrane, which is required for the uptake of positively charged
molecules including positively charged antimicrobials such as ami-
noglycosides.8 The interrupted ETC in SCVs results in reduced
uptake of aminoglycosides and hence increased resistance to
aminoglycosides.
Given that most natural AMPs are cationic, there is the possibil-
ity that S. aureus SCVs will be more resistant to these molecules
than the strains from which they arise. In fact, S. aureus SCVs have
been reported to have increased resistance to a number of cationic
AMPs including protamine,9 thrombin-induced platelet microbici-
dal protein10 and bovine lactoferricin B.11 To complicate matters
AMPs could select for AMP-resistant SCVs. Pranting and
Andersson12 reported that the cationic AMP protamine selects for
Salmonella enterica serovar Typhimurium SCVs, which were found
to be more resistant to a range of other AMPs, including colistin,
lactoferricin and the human defensin HNP-1.
It has recently been reported that S. aureus SCVs have decreased
susceptibility to a few skin-derived antimicrobial peptides.13 In this
study the authors also examined the activity of LL-37 against SCVs
and found there were strain-dependent differences in the suscepti-
bility. Three strains that had undefined genetic mutations resulting
in the SCV phenotype had between 2- and 4-fold reduced
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susceptibility to LL-37, while a defined SCV mutant with a disruption
in hemB was no less susceptible to LL-37.13 Because the mutations
in three of the SCVs were not defined, the variance in LL-37 suscepti-
bility found could have been due to strain differences or due to dif-
ferent gene mutations giving rise to the SCV in the different strains.
Aside from the skin, LL-37 is expressed by many cell types, in differ-
ent tissues and in body fluids.14 The antimicrobial activity of LL-37 in
various sites in the human body may vary since it has been shown
that bacterial susceptibility to antimicrobial peptides is dependent
on the ionic environment of the host. In particular bicarbonate has
been suggested to be a crucial ionic factor affecting bacterial
susceptibility to LL-37.15
In the study described here we examined the antimicrobial activ-
ity of the human cathelicidin LL-37 against S. aureus SCVs and deter-
mined if physiological levels of bicarbonate affected this activity.
Materials and methods
Bacterial strains and culture conditions
The bacterial strains used in this study are summarized in Table S1 (avail-
able as Supplementary data at JAC Online). Escherichia coli was grown
under aerobic conditions in LB broth at 37 C. S. aureus strains were grown
under aerobic conditions in tryptic soy broth (Sigma–Aldrich, T8907) at 37 C
with shaking at 200 rpm. Erythromycin was added to 5 mg/L and chloram-
phenicol was added to 10 mg/L where required for propagation of bacteria.
An SH1000 rsbUVWsigB mutant was constructed by phage transduction of
the rsbUVWsigB::ermB mutation from S. aureus LS-1 rsbUVWsigB::ermB
using ø85 as described by Nair et al.16 A markerless mutant of aroD in strain
8325-4 was constructed as described for strain LS-1 by Zhang et al.6
MBC assays
The susceptibility of S. aureus WT and mutants to LL-37 in the presence or
absence of bicarbonate was determined by measuring MBCs. The MBC assay
buffer was a modified version of that described by Dorschner et al.15 and con-
sisted of 1 mM NaH2PO4 with or without 50 mM NaHCO3 at pH 7.4. MBC
assays were performed according to a method described previously.3 Briefly,
1%104 cells from overnight bacterial cultures were inoculated into 100lL of
assay buffer containing LL-37 at 0, 1, 2, 4, 8, 16, 32, 64 or 128 mg/L. Samples
were incubated at 37 C for 2 h and then serial dilutions were plated onto
tryptone soya agar to determine the number of viable cells. The numbers
of the viable cells in each well were compared with the control that had no
LL-37 and the MBC was defined as the lowest concentration resulting in
99.9% kill.
Results
Susceptibility of SCVs to LL-37 in the presence and
absence of bicarbonate
To replicate mutations that give rise to S. aureus SCVs in clinical iso-
lates we constructed and/or used pre-existing S. aureus SCVs with
disruptions or deletions in three genes, aroD, hemB or menD . The
hemB gene encodes 5-aminolevluniate dehydratase, an enzyme
that is required for haem biosynthesis and hence cytochrome
function. The menD gene encodes 2-succinyl-5-enolpyruvyl-6-
hydroxy-3-cyclohexene-1-carboxylate synthase, an enzyme
involved in menaquinone biosynthesis. The gene aroD encodes
3-dehydroquinate dehydratase, which is part of the shikimate
pathway and is responsible for the synthesis of chorismate, a
branching point for the biosynthesis of menaquinone, aromatic
amino acids and several other metabolites. Therefore, all three
mutants have a defective ETC.
The MBCs of LL-37 for the S. aureusWT strains LS-1 and 8325-4,
and their isogenic SCVs, in the presence or absence of bicarbonate
are summarized in Table 1. All of the SCVs had the same suscepti-
bility to LL-37 as their respective WT strain in the absence of bicar-
bonate. In the presence of bicarbonate, the two WT strains
behaved differently, with the susceptibility of LS-1 to LL-37
decreasing 2-fold, while that of 8325-4 remained the same. All of
the SCVs derived from LS-1 demonstrated a .8-fold increase in
resistance to LL-37 (MBC.128 mg/L) compared with the WT strain
(MBC"16 mg/L). Interestingly, of the 8325-4 derived strains, only
the SCV defective in aroD, but not those with hemB ormenDmuta-
tions, showed a high level of bicarbonate-induced resistance to
LL-37 (MBC"128 mg/L). Complementing a functional aroD gene
into both LS-1 DaroD and 8325-4 DaroD negated the bicarbonate-
dependent resistance to LL-37. The reason for the difference in
response to bicarbonate by the SCVs of the two different WT
strains must have been due to genetic differences in the lineages.
It is established that strain 8325-4 is defective in RsbU and TcaR,17
and we have established that LS-1 is not.16 RsbU is a positive regu-
lator of the alternate sigma factor, rB, which is involved in
response to stress.18 TcaR is a regulator of the teicoplanin-
associated operon tcaRAB, which has been implicated in resistance
to the antibiotics teicoplanin and methicillin,19 but it is also a posi-
tive regulator of the global regulatory element SarS and the viru-
lence factor protein A.17 We therefore focused on these genetic
differences between the two lineages to see if they accounted for
the difference in bicarbonate-inducible LL-37 resistance in the
SCVs of these two strain backgrounds.
Effect of deleting the rB operon on bicarbonate-induced
resistance to LL-37
The susceptibility of SH1000 rsbUVWsigB, which is essentially
8325-4 with a deletion of the entire alternate sigma factor operon,
and LS-1 rsbUVWsigB in the presence and absence of bicarbonate
was determined and compared with the WT strains, as summar-
ized in Table 2. Deletion of the entire sigB operon had no effect on
Table 1. MBC (mg/L) of LL-37 for different S. aureus SCVs in sodium







LS-1 8 16 (16–32)
LS-1 DhemB 8 .128
LS-1 DmeD 8 .128
LS-1 DaroD 8 .128
LS-1 DaroD pSK236::aroD 8 16 (8–16)
8325-4 8 (4–8) 8 (8–16)
8325-4 DhemB 8 8 (8–16)
8325-4 DmenD 8 8 (8–16)
8325-4 DaroD 8 128 (64–128)
8325-4 DaroD pSK236::aroD 8 (4–8) 16 (16–32)
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the susceptibility of the 8325-4 lineage to LL-37 in the presence or
absence of bicarbonate. Upon deletion of the sigB operon in LS-1
there was a 2-fold increase in the susceptibility to LL-37 in the
absence of bicarbonate; however, this mutant still responded to
bicarbonate with a 2-fold decrease in susceptibility to LL-37. These
results suggested that the sigB operon may not be important in
bicarbonate-induced high-level resistance to LL-37.
Effect of repairing rsbU in strain 8325-4 on bicarbonate-
induced resistance to LL-37
Unexpectedly we found that SH1000 (RsbU-repaired 8325-4) had
high-level resistance to LL-37 in the presence of bicarbonate
(Table 2; MBC.128 mg/L). This was unexpected because LS-1,
which has an intact rsbU, does not display bicarbonate-inducible
high-level resistance to LL-37. The finding that repairing the rsbU
defect in 8325-4 resulted in bicarbonate-inducible high-level
resistance to LL-37 demonstrates that the rsbUVWsigB operon
does play a role in this process. Since LS-1 has an intact
rsbUVWsigB operon and does not display this phenotype, it sug-
gested that the TcaR defect in SH1000 may also play a role in
bicarbonate-inducible high-level resistance to LL-37.
Mutants defective in tcaR display bicarbonate-
dependent high-level resistance to LL-37, which can be
abolished by either repairing tcaR or deleting sigB
To determine if TcaR accounts for the difference in bicarbonate-
induced high-level resistance to LL-37 between strains LS-1 and
SH1000, a set of strains derived from the NCTC 8325 lineage were
utilized (Figure 1).17 Strain NCTC 8325 is known to be defective in
both rsbU and tcaR, and contains three prophages ø11, ø12 and
ø13. Strain 8325-4 used in the initial experiments described here is
a derivative of NCTC 8325 cured of the prophages. Strains HG001,
HG002 and HG003 were modified directly from strain NCTC 8325
by repairing rsbU, tcaR or both genes, respectively.17 The MBC of
LL-37 for each of these isogenic strains was determined and the
results are shown in Table 3. All of the strains had a similar level of
resistance to LL-37 in the absence of bicarbonate. As found in
previous experiments in this study, the two rsbU#tcaR# strains,
8325-4 and SH1000 DrsbUVWsigB, did not have high levels of
resistance to LL-37 in the presence of bicarbonate. In all strains
where rsbUwas repaired, but in which tcaRwas defective, i.e. strains
SH1000 and HG001 (rsbU!tcaR#), the presence of bicarbonate-
induced high-level resistance to LL-37 (MBC128 mg/L). This
suggests that RsbU, through regulation of rB, positively regulates
the bicarbonate-inducible high-level resistance to LL-37 phenotype
in tcaR-defective strains. When tcaRwas repaired in a strain compe-
tent for RsbU, i.e. strain HG003 (rsbU!tcaR!), the bicarbonate-
inducible high-level resistance to LL-37 phenotype was lost. This
suggests that TcaRAB and SigB operons have opposite effects in the
regulation of bicarbonate-inducible high-level resistance to LL-37.
Furthermore, the rsbU#tcaR! strain HG002 showed a similar level
of resistance to LL-37 in the presence of bicarbonate as the
rsbU!tcaR! strain HG003, demonstrating that when TcaR is func-
tioning, deleting or repairing rsbU does not affect the high-level
resistance to LL-37 phenotype in the presence of bicarbonate.
From these data it is apparent that bicarbonate does not induce the
high-level resistance to LL-37 phenotype in strains with a tcaR!
genotype and only strains with the genotype rsbU!tcaR# exhibit
bicarbonate-dependent high-level resistance to LL-37.
Discussion
S. aureus SCVs are a subpopulation of cells that are slow growing
and able to survive and persist in the host.1 One of the important
features of SCVs is an increased resistance to aminoglycosides20
conferred by a disrupted ETC.21 To investigate whether a defective
ETC also increases SCV resistance to cationic AMPs, the activity of
LL-37 against S. aureus haemin and menadione auxotrophs was
determined. SCVs that had mutations in hemB, menD or aroDwere
found to be as susceptible to LL-37 as their parental strains, dem-
onstrating that the disrupted ETC in these SCVs, which would result
in reduced membrane potential, does not confer resistance to
LL-37. These findings to a small extent contrast with those of
Glaser et al.13 who found that three out of four SCVs that they
examined had slightly increased resistance to LL-37. However,
in their study, the nature of the genetic change conferring an
SCV phenotype on the three SCVs that had increased resistance to
LL-37 was not defined, nor was it determined if these strains con-
tained additional mutations. The SCV strain that did not have an
increased resistance to LL-37 was a defined mutant that was iden-
tical to the 8325-4 hemBmutant used in this study. Therefore pos-
sible explanations for the findings of Glaser et al.13 could include:
(i) SCV phenotypes that result from different gene mutations have
different levels of resistance to LL-37; (ii) SCVs in different strain
Table 2. Comparison of the MBC (mg/L) of LL-37 for S. aureus strains,
with or without an intact rsbU gene, in sodium phosphate buffer or in
sodium phosphate buffer supplemented with bicarbonate
Strain 1 mM NaH2PO4 1 mM NaH2PO4!NaHCO3
LS-1 8 16 (16–32)
LS-1 DrsbUVWsigB 4 (4–8) 8 (4–16)
8325-4 (rsbU#) 8 (4–8) 8
SH1000 (rsbU!) 8 .128
SH1000 DrsbUVWsigB 8 8
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Figure 1. Relationship between the NCTC 8325 lineage strains.
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backgrounds have different levels of resistance to LL-37; and
(iii) the SCV strains that had increased resistance to LL-37 had
additional mutations, unrelated to the SCV phenotype, which were
responsible for the increased resistance to LL-37. Since we exam-
ined SCVs that arose from different genetic mutations that are
commonly isolated in clinical settings the first explanation above
seems unlikely. The second explanation also seems unlikely since
we used very different strain backgrounds and did not find
increased resistance to LL-37. Hence the third explanation that
there were additional mutations in the genome of the SCVs, unre-
lated to the SCV phenotype, that conferred increased resistance to
LL-37 seems more likely; however, none of the other explanations
can be ruled out completely.
In the presence of physiological concentrations of bicarbonate
the hemB, menD and aroD SCVs of S. aureus LS-1 all demonstrated
high levels of resistance to LL-37 compared with the WT strain.
While an aroD SCV of strain 8325-4 had high-level resistance to
LL-37 in the presence of bicarbonate, neither the hemB SCV nor the
menD SCV of this strain had increased resistance. Our findings that
the WT S. aureus strains either had no change in resistance or
increased resistance to LL-37 in the presence of bicarbonate are at
odds with the data published by Dorschner et al.15 who found that
bicarbonate increased the susceptibility of S. aureus to LL-37. We
hypothesized that the strain-dependent differences in the resist-
ance of the LS-1 and 8325-4 SCVs to LL-37 in the presence of bicar-
bonate were probably due to known defects in two genes, rsbU
and tcaR, in the NCTC 8325 strain lineage. Indeed, when rsbU was
repaired in strains of the NCTC 8325 lineage they demonstrated
high-level resistance to LL-37 in the presence of bicarbonate.
Repairing tcaR or inactivating rsbU abolished high-level resistance
to LL-37 in the presence of bicarbonate. RsbU is a positive regulator
of the alternate sigma factor rB, which is important for S. aureus
responses to environmental stress, survival and virulence.22,23
Expression of rB is increased in S. aureus SCVs and has been
reported to be the major regulator of virulence in cells of this phe-
notype.24 Overexpression of rB leads to increased cell wall
thickness25 and it is tempting to speculate that this may in part
account for the high-level resistance to LL-37 seen in SCVs in the
presence of bicarbonate. TcaR, the teicoplanin-associated locus
regulator, is a MarR family protein initially identified as the regula-
tor of a teicoplanin-resistance-associated locus, which consists of
tcaR, tcaA and tcaB (tcaRAB).19 TcaR is now recognized to be a mul-
tifunctional regulator, regulating genes involved in polysaccharide
intercellular adhesin production26 and sarS, a member of the
global regulatory network.27 Deletion of the tcaRAB locus leads to
increased resistance to glycopeptide antibiotics and some clinical
isolates of glycopeptide-intermediate-resistant S. aureus (GISA)
harbour mutations in the tcaRAB locus, which accounts for this
resistance.28 Whilst it is clear that defects in the tcaRAB operon can
give rise to clinical GISA, the exact mechanisms behind this are not
known. GISA have thickened cell walls with altered compositions
and it has been suggested that these thickened cell walls seques-
ter glycopeptides before they can reach their membrane located
target lipid II.29,30 The GISA phenotype has also been linked to
low-level resistance to cationic thrombin-induced platelet microbi-
cidal proteins.31 However, in the case of LL-37 the thickened cell
wall on its own cannot account for the high-level resistance of
S. aureus, since physiological levels of bicarbonate are required for
this phenotype. Mirroring our findings on bicarbonate-induced
high-level resistance to LL-37 in S. aureus, rB plays an important
role in increased resistance to teicoplanin and vancomycin in GISA
that have a defect in the tcaRAB locus.28 Taken together these
data suggest that some clinical GISA will have an increased resist-
ance to LL-37 in vivo and may therefore have a survival advantage.
Exactly howrB regulates glycopeptide resistance is not known, but
it does so through a secondary regulator encoded by the yabJ-
spoVG operon.32
In summary, the data generated in this study highlight that the
physiological ionic component bicarbonate needs to be factored
into studies on the resistance of bacteria to antimicrobial peptides.
Our data also infer that some GISA may have high-level resistance
to LL-37 in vivo.
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Table 3. Comparison of the MBC (mg/L) of LL-37 for S. aureus strains of the NCTC 8325 lineage, with or without defects in the rsbU and/or tcaR genes,
in sodium phosphate buffer or in sodium phosphate buffer supplemented with bicarbonate
Strain Genotype 1 mM NaH2PO4 1 mM NaH2PO4!NaHCO3
8325-4 rsbU#, tcaR# 8 (4–8) 8
SH1000 rsbU!, tcaR# 8 .128
SH1000 DrsbUVWsigB rsbU#, tcaR# 8 8
HG001 rsbU!, tcaR#, ø11, ø12, ø13 8 128
HG002 rsbU#, tcaR!, ø11, ø12, ø13 8 16 (16–32)
HG003 rsbU!, tcaR!, ø11, ø12, ø13 8 16 (16–32)
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